Search
Now showing items 21-30 of 63
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells
Schneider, Edith et al. (2020)
Wissenschaftlicher Artikel
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Edelmann, Jennifer et al. (2020)
Wissenschaftlicher Artikel
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
Jahn, Nikolaus et al. (2020)
Wissenschaftlicher Artikel
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1
Tausch, Eugen et al. (2020)
Wissenschaftlicher Artikel
Towards precision medicine for AML
Döhner, Hartmut; Wei, Andrew H.; Löwenberg, Bob (2021)
Wissenschaftlicher Artikel
Model-Based Optimal AML Consolidation Treatment
Jost, Felix et al. (2020)
Wissenschaftlicher Artikel
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
Estey, Elihu; Hasserjian, Robert P.; Döhner, Hartmut (2022)
Wissenschaftlicher Artikel
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
Voso, Maria Teresa et al. (2020)
Wissenschaftlicher Artikel
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
Montesinos, Pau et al. (2020)
Wissenschaftlicher Artikel
Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study
Schlenk, Richard Friedrich et al. (2020)
Wissenschaftlicher Artikel